Malcova
Newark, US · Founded 2022
Malcova develops medical imaging technology, including a Narrow-Beam CT system, aimed at early detection of diseases such as breast cancer and stroke with lower radiation and reduced patient discomfort. Its tools are intended for radiologists and healthcare providers to support more accurate diagnosis.
Founders & leadership
PG
Peymon GhaziNamed on SEC filing
TG
Tara GhaziNamed on SEC filing
MS
Moushmi SolejaNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$1.2M disclosed across 1 round · 2026
▶$1.2MraisedSep 2026 · 12 investors · Other TechnologyRule 506(b)
▶$1.2MraisedSep 2026 · 12 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Peymon GhaziExecutive Officer, Director
- Tara GhaziExecutive Officer, Director
- Moushmi SolejaDirector
- Offering amount
- $2M
- Amount sold
- $1.2M
- Minimum investment
- $5K
- Proceeds to insiders
- $200K
- First sale
- Aug 2026
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Malcova do?
- Malcova develops medical imaging technology, including a Narrow-Beam CT system, aimed at early detection of diseases such as breast cancer and stroke with lower radiation and reduced patient discomfort. Its tools are intended for radiologists and healthcare providers to support more accurate diagnosis.
- How much funding has Malcova raised?
- Malcova has disclosed $1.2M raised across 1 round.
- Where is Malcova headquartered?
- Malcova is headquartered in Newark, US.